Gyeongsangbuk-do, South Korea

Yosep Ji

This inventor holds 1 USPTO granted patent. Top assignees: Atogen Co., Ltd, Handong Global University Industry-Academic Cooperation Foundation. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yosep Ji. Retrieved from https://idiyas.com/inventor/yosep-ji-qmt0ka05

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yosep Ji: Innovator in Probiotic Strains

Introduction

Yosep Ji is a notable inventor based in Gyeongsangbuk-do, South Korea. He has made significant contributions to the field of probiotics, particularly in developing strains that have therapeutic benefits. His work focuses on addressing metabolic diseases and inflammation through innovative probiotic solutions.

Latest Patents

Yosep Ji holds a patent for the HAC01 strain, which demonstrates anti-inflammatory efficacy and the ability to alleviate metabolic diseases. The patent describes a probiotic preparation, an anti-inflammatory composition, and a health food composition that includes the HAC01 strain or its derivatives as active ingredients. This invention aims to improve health outcomes for individuals suffering from metabolic disorders.

Career Highlights

Throughout his career, Yosep Ji has worked with various organizations, including Atogen Co., Ltd and the Handong Global University Industry-Academic Cooperation Foundation. His experience in these institutions has allowed him to advance his research and contribute to the development of effective probiotic solutions.

Collaborations

Yosep Ji has collaborated with notable individuals in his field, including Wilhelm Holzapfel and Hyeunkil Shin. These partnerships have enriched his research and expanded the impact of his innovations.

Conclusion

Yosep Ji's work in developing the HAC01 strain showcases his commitment to improving health through innovative probiotic solutions. His contributions to the field of metabolic disease treatment highlight the importance of research and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…